Goldman Sachs removed Watson Pharmaceuticals (NYSE: WPI) from its Conviction Buy List, but maintained a Buy rating. The price ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE